WO170
WO170 is a KCNT1 inhibitor that can be used in studies related to diseases associated with KCNT1 dysfunction, such as epilepsy.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3109711-34-1
- Fòrmula: C25H21N5O
- Peso molecular:407.47
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 3109711-34-1
-
Peso molecular 407.47
-
Fòrmula C25H21N5O
-
SMILES
N#CC1=CC2=C(N[C@H]3CCCC4=C3N=C(O4)C5=CC(C6CC6)=NC=C5)N=CC=C2C=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
WO170 Related Classifications
HY-187836 Related Classifications
Powered by Bioz
Keywords
- WO170
- 3109711-34-1
- WO 170
- WO-170
- Drug Derivative
- refractory epilepsy
- post-traumatic epilepsy
- focal epilepsy
- infantile epilepsy with migrating focal seizures
- KCNT1
- generalized epilepsy
- sleep-related hypermotor epilepsy
- autosomal dominant nocturnal frontal lobe epilepsy
- epilepsy
- epileptic encephalopathy
- Inhibitor
- inhibitor
- inhibit